Our study suggested DDR1 and STAT3 formed a positive feedback pathway, synergistically promoted the progression of HCC, thus providing new evidence and new targets for the treatment of targeting glutamine metabolism in hepatocellular carcinoma. This evidence concerns the gene DDR1 and hepatocellular carcinoma.